GB1342286A - Treatment of alopecia - Google Patents
Treatment of alopeciaInfo
- Publication number
- GB1342286A GB1342286A GB913371A GB913371A GB1342286A GB 1342286 A GB1342286 A GB 1342286A GB 913371 A GB913371 A GB 913371A GB 913371 A GB913371 A GB 913371A GB 1342286 A GB1342286 A GB 1342286A
- Authority
- GB
- United Kingdom
- Prior art keywords
- treatment
- dopa
- alopecia
- compounded
- preparations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1342286 L-dopa preparations H TAKAHASHI 8 April 1971 [6 Nov 1970] 9133/71 Heading A5B L-dopa preparations for the treatment of alopecia comprise L-dopa either (a) compounded with HCl, NaHSO 3 , NaOH and water for parenteral administration, (b) compounded with allantoin and lanolin for topical application or (c) contained in gelatin capsules for oral administration. The topical preparation may be a lotion or cream.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9814670 | 1970-11-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1342286A true GB1342286A (en) | 1974-01-03 |
Family
ID=14212042
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB913371A Expired GB1342286A (en) | 1970-11-06 | 1971-04-08 | Treatment of alopecia |
Country Status (3)
Country | Link |
---|---|
DE (1) | DE2117762A1 (en) |
FR (1) | FR2112483B1 (en) |
GB (1) | GB1342286A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1348421A2 (en) * | 2002-03-25 | 2003-10-01 | L'oreal | A method of thickening and styling human keratinous fibres using a particular catalytic system |
US6696600B2 (en) | 2001-11-13 | 2004-02-24 | Teva Pharmaceutical Industries, Ltd. | L-DOPA ethyl ester salts and uses thereof |
FR2847805A1 (en) * | 2002-11-28 | 2004-06-04 | Oreal | Use of a combination of an ortho-dihydroxy aromatic compound and a catalyst comprising manganese and/or zinc and bicarbonate for increasing hair density and/or treating androgenic alopecia or for hair styling |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2259646C2 (en) * | 1972-12-06 | 1984-11-22 | Hoechst Ag, 6230 Frankfurt | High-dose tablets of cephalosporin derivatives, as well as processes for their manufacture |
US4021538A (en) * | 1975-09-29 | 1977-05-03 | Yu Ruey J | Method for producing pigmentation in hair or skin |
IT1258069B (en) * | 1992-04-10 | 1996-02-20 | COMPOSITION FOR TOPICAL USE WITH STIMULUS ACTIVITY FOR GROWTH, REGENERATION, PREVENTION OF ENRIGEMENT AND NATURAL REPIGMENTATION OF HAIR |
-
1971
- 1971-04-07 DE DE19712117762 patent/DE2117762A1/en active Pending
- 1971-04-08 GB GB913371A patent/GB1342286A/en not_active Expired
- 1971-04-09 FR FR7112703A patent/FR2112483B1/fr not_active Expired
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6696600B2 (en) | 2001-11-13 | 2004-02-24 | Teva Pharmaceutical Industries, Ltd. | L-DOPA ethyl ester salts and uses thereof |
EP1348421A2 (en) * | 2002-03-25 | 2003-10-01 | L'oreal | A method of thickening and styling human keratinous fibres using a particular catalytic system |
EP1348421A3 (en) * | 2002-03-25 | 2004-01-02 | L'oreal | A method of thickening and styling human keratinous fibres using a particular catalytic system |
FR2847805A1 (en) * | 2002-11-28 | 2004-06-04 | Oreal | Use of a combination of an ortho-dihydroxy aromatic compound and a catalyst comprising manganese and/or zinc and bicarbonate for increasing hair density and/or treating androgenic alopecia or for hair styling |
Also Published As
Publication number | Publication date |
---|---|
FR2112483B1 (en) | 1975-06-06 |
FR2112483A1 (en) | 1972-06-16 |
DE2117762A1 (en) | 1972-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1198764A (en) | A Urate Oxidase and process for the production thereof | |
AU476000B2 (en) | 2-amino-2', 6'-propionoxylidide and its therapeutically acceptable salts | |
GB1342286A (en) | Treatment of alopecia | |
SE302176B (en) | ||
AU467578B2 (en) | New cyclic urea derivatives and salts thereof process forthe production thereof and pharmaceutical preparations containing thesame | |
GB1239965A (en) | Cosmetic preparations | |
GB1421229A (en) | Pharmaceutical compositions comprising ergot alkaloid and vitamins | |
HK57477A (en) | 3'-4'-dideoxykanamycin b active against resistant bacteria, and its synthesis | |
IE35711L (en) | Pharmaceutical compositions | |
GB1337093A (en) | Pharmaceutical preparation for the treatment of local oedemas | |
IE33519L (en) | Benzylhydrazides | |
GB1386927A (en) | Preparations for combatting swine dysentery | |
ZA74404B (en) | 4,8-dimethoxy-furo(3',2'-f)benzoxazol-2-yl acethydroxamic acid,its process of preparation and its therapeutic application | |
GB1430726A (en) | Pharmaceutical preparations containing resorcinol deirvatives | |
GB1292794A (en) | Pharmaceutical compositions | |
GB1279380A (en) | Improvements in or relating to hydantoins and compositions thereof | |
CA849004A (en) | Dermatological preparations containing pilosine, isopilosine and their salts | |
GB1392004A (en) | Propoxyphene salts | |
GB1242742A (en) | Drug for stimulating the central nervous system | |
IE33520L (en) | Benzylhydrazides | |
GB1475651A (en) | Pharmaceutical composition for the treatment of cancer | |
AU448357B2 (en) | ANTISEBORRHOEIC LACQUERS AND WAVE SETTING LOTIONS Additional to 412186) | |
CA839254A (en) | 6,1'spirocyclopropyl pregnanes and their preparation | |
GB1305179A (en) | ||
GB1414831A (en) | Anti-influenza medicinal preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PE20 | Patent expired after termination of 20 years |